Back to Cresset Asset Management, LLC Cresset Asset Management, LLC

PVLA

7 quarters

Position history for Cresset Asset Management, LLCCresset Asset Management, LLC's holdings in Palvella Therapeutics, Inc.

Yes. Cresset holds 11,629 shares of PVLA (Palvella Therapeutics), worth $1.8M, as of its Q2 2026 13F filing. It reduced the position by 231 shares (-2.0%) from Q1 2026. Cresset has held PVLA since Q4 2024, across 7 quarterly 13F filings.

Current Value

$1.8M

Current Shares

11,629

Total Value Change

+$1.5M

Total Shares Change

-9,282

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
11,629
-1.9%
$1.8M0.0%$152.82
0
2026-Q1
Increased
11,860
+3.8%
$1.5M0.0%$124.65
27
2025-Q4
Decreased
11,429
-34.4%
$1.2M0.0%$104.67
0
2025-Q3
Decreased
17,424
-16.7%
$1.1M0.0%$62.69
0
2025-Q2
Unchanged
20,911
0.0%
$471,3340.0%$22.54
0
2025-Q1
Unchanged
20,911
0.0%
$585,2990.0%$27.99
0
2024-Q4
New
20,911
-
$250,9320.0%$12.00
32

Other major holders of PVLA: Jennison Associates LLC, BlackRock, Inc., State Street Corp., T. Rowe Price Associates, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used